Select a Country Careers Partnerships Investors Newsroom
PARTNERSHIPS LICENSING AREAS OF INTEREST PROCESS OVERVIEW submit opportunity
INVESTORS INVESTOR RESOURCES REPORTS & FINANCIALS STOCK Information EVENTS & PRESENTATIONS Corporate Governance
Newsroom Press Releases Media Contacts

Resources and archives for the news media

This archive of news releases for AbbVie is intended to be a resource for the news media that covers our business, innovations, and products, and a library for anyone interested in our business. If you are a member of the news media and have questions or need additional information, please contact our Public Affairs Team.

Please note that prior to January 1, 2013 AbbVie was a part of Abbott. AbbVie-related press releases that were issued prior to January 1, 2013 will link to the original press release titles (housed on Abbott.com).

The 5 most recent press releases appear below. Click the year link to access all the releases for that period.

Archives: Search / 2014 / 2013 / 2012

Sep 11, 2014
- Currently no approved treatment options available for patients living with HS, a skin disease which impacts approximately 1 percent of the adult population worldwide1,2
Sep 3, 2014
- Calico to create a leading R&D facility in the San Francisco Bay Area focused on aging and age-related diseases, including neurodegeneration and cancer
Sep 3, 2014
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones -
Aug 18, 2014
- Recipients will compete for public votes for a chance to win one of two Thriving Undergraduate and Graduate Scholar awards
 

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

EXIT ABBVIE.COM

The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.

As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to continue to this product-specific site?